CACNG2-DT
geneOn this page
Summary
CACNG2-DT (CACNG2 divergent transcript, HGNC:55682) is a long non-coding RNA gene on chromosome 22q12.3.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:55682 |
| Approved symbol | CACNG2-DT |
| Name | CACNG2 divergent transcript |
| Location | 22q12.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000234688 |
| Ensembl biotype | lncRNA |
| Entrez | 105373021 |
| RNAcentral | URS0000A77622 — lncRNA, 556 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 7 lncRNA
ENST00000430281, ENST00000732668, ENST00000732669, ENST00000732670, ENST00000732671, ENST00000732672, ENST00000732673
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000430281 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004063224 | 36720916 | 36721874 |
| ENSE00004063235 | 36703577 | 36703992 |
Expression profiles
Bgee: expression breadth broad, 71 present calls, max score 73.38.
Top tissues by expression
71 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right hemisphere of cerebellum | UBERON:0014890 | 73.38 | gold quality |
| cerebellum | UBERON:0002037 | 72.39 | gold quality |
| cerebellar cortex | UBERON:0002129 | 72.39 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 72.37 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 70.20 | gold quality |
| prefrontal cortex | UBERON:0000451 | 70.08 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 70.00 | gold quality |
| frontal cortex | UBERON:0001870 | 69.97 | gold quality |
| right frontal lobe | UBERON:0002810 | 69.73 | gold quality |
| cortical plate | UBERON:0005343 | 69.52 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 69.17 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 69.09 | gold quality |
| cerebral cortex | UBERON:0000956 | 68.61 | gold quality |
| putamen | UBERON:0001874 | 68.55 | gold quality |
| brain | UBERON:0000955 | 66.93 | gold quality |
| nucleus accumbens | UBERON:0001882 | 66.41 | gold quality |
| ganglionic eminence | UBERON:0004023 | 66.33 | gold quality |
| caudate nucleus | UBERON:0001873 | 66.29 | gold quality |
| hypothalamus | UBERON:0001898 | 65.96 | gold quality |
| amygdala | UBERON:0001876 | 65.22 | gold quality |
| temporal lobe | UBERON:0001871 | 65.11 | gold quality |
| substantia nigra | UBERON:0002038 | 64.60 | gold quality |
| primary visual cortex | UBERON:0002436 | 63.27 | gold quality |
| multicellular organism | UBERON:0000468 | 62.15 | gold quality |
| Ammon’s horn | UBERON:0001954 | 61.63 | gold quality |
| omental fat pad | UBERON:0010414 | 59.29 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 57.11 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 56.84 | gold quality |
| adipose tissue | UBERON:0001013 | 56.42 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 55.99 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.81 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Bardet-Biedl syndrome, Bardet-Biedl syndrome 19, Jeune syndrome